Effect of preparation method on complexation of Cefdinir with β-cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 67, Issue 1-2, 2010, Pages 39-47

  Mohit, Vij ^a   Harshal, Garse ^a   Neha, Dand ^a   Vilasrao, Kadam ^a   Rajashree, Hirlekar ^a  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

cyclodextrin; Cefdinir; Complexation; Dissolution rate; Microwave irradiation method

Indexed keywords

EID: 77952319303     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-009-9666-y     Document Type: Article

References (26)

1. Cabri, W., Ghetti, P., Alpegiani, M., Pozzi, G., Justo-Erbez, A., Perez-Martinez, J. I., Villalon-Rubio, R., Monedero-Perales, M. C., Munoz-Rubio, A.: Cefdinir: a comparative study of anhydrous vs. monohydrate form microstructure and tableting behaviour. Eur. J. Pharm. Biopharm. 64, 212-221 (2006). doi: 10. 1016/j. ejpb. 2006. 05. 007.
2. Inamoto, Y., Chiba, T., Kamimura, T., Takaya, T.: FK 482, a new orally active cephalosporin synthesis and biological properties. J. Antibiot. 41, 828-830 (1988).
3. Neu, H. C., Saha, G., Chin, N. X.: Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin. Antimicro. Agents chemother. 33, 1795-1800 (1989).
4. Mine, Y., Yokota, Y., Wakai, Y., Kumimura, T., Tawara, S., Shibayama, F., Kikuchi, H., Kuwahara, S.: In vivo antibacterial activity of FK482, a new orally active cephalosporin. J. Antibiot. 41, 1888-1895 (1988).
5. Perry, C. M., Scott, L. J.: Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Drugs 64, 1433-1464 (2004).
6. Miller, L. A., Carrier, R. L., Ahmed, I.: Practical considerations in development of solid dosage forms that contain cyclodextrin. J. Pharm. Sci. 96, 1691-1707 (2007). doi: 10. 1002/jps. 20831.
7. Duchene, D., Wouessidjewe, D.: Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm. 16(17), 2487-2499 (1990).
8. Szente, L., Atwood, J. L., Davies, J. E. D., MacNicol, D. D., Vogtle, F.: Comprehensive supramolecular chemistry, vol 3, p. 243. Elsevier Science Ltd, New York (1996).
9. Zhao, D. Y., Yang, S. G., Hu, M., Ma, X. Y.: Structural study of inclusion complex of andrographolide with β-cyclodextrin prepared under microwave irradiation. Chin. Chem. Lett. 14, 155-158 (2003).
10. Zhao, D., Liao, K., Ma, X., Yan, N.: Study of supramolecular inclusion of β-cyclodextrin with andrographolide. J. Incl. Phenom. Macrocycl. Chem. 43, 259-264 (2002).
11. Shen, Y., Yang, S., Wu, L., Ma, X.: Study on structure and characterisation of inclusion complex of gossypol/beta cyclodextrin. Spectrochem. Acta A 61, 1025-1028 (2005).
12. Wen, X., Tan, F., Jing, Z., Liu, Z.: Preparation and study the 1: 2 inclusion complex of carvedilol with β-cyclodextrin. J. Pharm. Biomed. Anal. 34, 517-523 (2004).
13. Aleem, O., Kuchekar, B., Pore, Y., Late, S.: Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. J. Pharm. Biomed. Anal. 47, 535-540 (2008). doi: 10. 1016/jpba. 2008. 02. 006.
14. Ren, Y., Gao, J., Han, B., Ma, X.: Medical composition containing cyclodextrin inclusion compound of cefdinir and its preparation method. PCT Int. Appl. PCT/CN2008/000514 (2008).
15. Higuchi, T., Connors, K. A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965).
16. Hirlekar, R., Kadam, V.: Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 63, 219-224 (2009). doi: 10. 1007/s10847-008-9506-5.
17. Nie, S., Fan, X., Peng, Y., Yang, X., Wang, C., Pan, W.: In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-β-cyclodextrin. Arch. Pharm. Res. 30, 991-1001 (2007).
18. Esclusa-Diaz, M. T., Torres-Labandeira, J. J., Kata, M., Vila-Jato, J. L.: Inclusion complexation of glibenclamide with 2-hydroxypropyl-β-cyclodextrin in solution and in solid state. Eur. J. Pharm. Biopharm. 1, 291-296 (1994).
19. Bodmeier, R., Chen, H.: Preparation of biodegradable poly(±)lactide microparticles using a spray-drying technique. J. Pharm. Pharmacol. 40, 754-757 (1988).
20. Moneghini, M., Bellich, B., Baxa, P., Princivalle, F.: Microwave generated solid dispersions containing ibufrofen. Int. J. Pharm. 361, 125-130 (2008).
21. Manca, M. L., Zaru, M., Ennas, G., Valenti, D., Cinico, C., Loy, G., Fadda, A. M.: Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies. AAPS PharmSciTech. 6(3), 58 (2008).
22. Mura, P., Maestrelli, F., Cirri, M., Furlanetto, S., Pinzauti, S.: Differential scanning calorimetry as tools in the study of drug-cyclodextrin interactions. J. Therm. Anal. Calorim. 74, 769-777 (2003).
23. Benesi, H., Hildebrand, J.: A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbon. J. Am. Chem. Soc. 71, 2701-2705 (1949).
24. Zingone, G., Rubessa, F.: Preformulation study of the inclusion complex warfarin-β-cyclodextrin. Int. J. Pharm. 291, 3-10 (2005).
25. Obaidat, A. A., Khanfar, R. A., Khawam, M. N.: The effect of b-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modelling. J. Incl. Phenom. Macrocycl. Chem. 63, 273-279 (2009). doi: 10. 1007/s10847-008-9517-2.
26. Trotta, F., Martina, K., Robaldo, B., Barge, A., Cravotto, G.: Recent advances in the synthesis of cyclodextrin derivatives under microwaves and power ultrasound. J. Incl. Phenom. Macrocycl. Chem. 57, 3-7 (2007).